ZYNE Shares Outstanding History



Below is a table of the ZYNE shares outstanding history going back to 8/5/2015:

Date ZYNE Shares Outstanding
8/5/20158.73M
8/27/20158.73M
11/12/20159.20M
3/10/20169.20M
5/11/20169.20M
8/9/20169.20M
11/11/20169.95M
3/24/201713.21M
5/5/201713.25M
7/28/201713.26M
11/10/201713.55M
3/8/201813.56M
5/4/201813.56M
7/31/201817.62M
11/5/201817.63M
3/7/201921.07M
5/6/201921.07M
8/2/201923.20M
8/5/2019117.61M
11/1/201923.20M
3/4/202023.56M
5/7/202024.95M
8/6/202029.26M
11/5/202029.44M
3/5/202141.25M
5/7/202141.25M
8/5/202141.25M
11/11/202141.22M
2/22/202242.45M
5/11/202243.60M
8/8/202245.75M
11/9/202247.06M
3/22/202353.35M
5/11/202353.65M
8/9/202353.94M

Also see: ZYNE Market Cap History
ZYNE YTD Return
ZYNE Historical Shares Outstanding:
+25.50% CAGR
ZYNE Historical Shares Outstanding: +25.50% CAGR

Mouse over chart for data details
8/5/2015 ...8/9/2023
Zynerba Pharmaceuticals is engaged in pharmaceutically-produced transdermal cannabinoid therapies for neuropsychiatric disorders. Co. is focused on improving the lives of patients and their families living with severe, chronic health conditions including Fragile X syndrome (FXS), autism spectrum disorder (ASD), and 22q11.2 deletion syndrome (22q). Co. is developing Zygel, the pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery and manufactured without the presence of tetrahydrocannabinol. Zygel is being developed as a clear gel with once- or twice-daily dosing and is targeting treatment of behavioral symptoms of FXS, ASD and 22q. We show 35 historical shares outstanding datapoints in our coverage of ZYNE's shares outstanding history.

Understanding the changing numbers of ZYNE shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ZYNE versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ZYNE by allowing them to research ZYNE shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree ZYNE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Zynerba Pharmaceuticals (ZYNE) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ZYXI Shares Outstanding History
A Shares Outstanding History
AAC Shares Outstanding History
AADI Shares Outstanding History
ABAX Shares Outstanding History
ABBV Shares Outstanding History
ABC Shares Outstanding History
ABEO Shares Outstanding History
ABIO Shares Outstanding History
ABMD Shares Outstanding History
More Healthcare companies »

 

ZYNE Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.